Syncona Ltd. is a closed-end investment fund. It engages in delivering returns from investments in long and alternative investment funds across multiple asset classes and targets. The company operates through the following segments: Life science portfolio and Capital pool investments. The Life science portfolio segment activities focuses on developing products to deliver transformational treatments to patients. The Capital pool investments segment invests in a diversified portfolio of hedge, equity and long-term alternative investment funds across multiple asset classes. Syncona was founded on August 14, 2012 and is headquartered in St. Peter Port, the United Kingdom.